Resources

The educational tools, resources, and news curated for those searching for peer-reviewed, clinical evidence on cannabinoids.

Ask the Experts article image

Ask the Experts: What Practical Information Do I Need to Know About Cannabinoids?

Join our expert faculty to learn more about artisanal formulations of cannabinoids and their use for medicinal purposes.

Medscape is a free educational website. However, if you are not already a member, you will be prompted to select a free username and password.

Article headline image - Learn about the hierarchy of evidence in an evidence-based approach to scientific testing.

Pyramid of Knowledge

Learn about the hierarchy of evidence in an evidence-based approach to scientific testing.

Image of two papers highlighting the practices of cannabis dispensary staff

Two Papers Highlight Practices of Cannabis Dispensary Staff

Dispensary staff are making recommendations for patients with minimal to no training of cannabis use for the specific medical condition.

Weeding out evidence on cognitive impact of cannabis from that of THC article image

Rolled Into One? Weeding Out Evidence on Cognitive Impact of Marijuana from that of THC

The review summarizes findings from English-only, peer-reviewed original articles and meta-analyses of specified cannabinoids’ effect on cognition in preclinical and clinical literature, where known, to guide practitioners with proper evidence and highlighting gaps in knowledge for future research.

Sorting Out the Differences and Legality of CBD, cannabis, and Hemp Products. Image of a pipette medicine dropper

Cannabis Confusion: Sorting Out the Differences and Legality of CBD, Marijuana, and Hemp Products

To provide psychiatric and neurologic pharmacists with a clear understanding of the distinctions between cannabis-derived substances such as cannabidiol (CBD), including legal issues, purity, safety, and efficacy of the FDA-approved CBD agent, OTC CBD products, and “street” products to enable pharmacists to effectively counsel and manage their patients.

This activity has expired, but content is available for viewing

Clinical Perspective on Cannabinoids: Barriers to Better Care Article Image

Clinical Perspectives on Cannabinoids: From Barriers to Better Care

A free, thematic curriculum for health care provider, dedicated to improving knowledge about cannabinoids.

Medscape is a free educational website. However, if you are not already a member, you will be prompted to select a free username and password.

Survey Identifies Gaps in Physician Knowledge About Cannabis and Cannabinoids image

Survey Identifies Gaps in Physician Knowledge About Cannabis and Cannabinoids

The Cannabis and Cannabinoids Knowledge Assessment Survey (CCKAS) was conducted in January 2020. Physicians were asked to complete an electronic multiple-choice questionnaire that assessed their level of knowledge about current FDA-approved cannabinoid-therapies, potential cannabis-related therapies, as well the current laws covering the use of cannabis for medical purposes and quality testing of existing non--FDA-approved cannabis products.

Image of documentation - cannabinoid knowledge and attitudes among US Healthcare providers

Cannabinoid Knowledge and Attitudes Among US Health Care Providers

Data from M. Szaflarski et al. examines US health care provider attitudes toward cannabis-based therapies, including the correlation of professional status with knowledge and attitudes regarding cannabis-based therapies.

Medscape company logo - AES Live Event: Straight Talk: The Intersection of Clinician and Patient Perspectives on Cannabinoids

AES Live Event: Straight Talk: The Intersection of Clinician and Patient Perspectives on Cannabinoids

Learn potential mechanisms for cannabinoids, clinical trial updates, and the strategies for communicating risk/benefit to families and caregivers.

Medscape is a free educational website. However, if you are not already a member, you will be prompted to select a free username and password.  

Lab research image – the WHO Expert Committee on Drug Dependence concluded that cannabidiol (in its pure state) does not appear to have abuse potential or cause harm.

WHO Recommends CBD Alone Should Not Be a Scheduled Substance

World Health Organization’s (WHO) Expert Committee on Drug Dependence concluded that cannabidiol (in its pure state) does not appear to have abuse potential or cause harm.

Glossary of cannabinoid terms page and visual representation and definition of the term innovation

Glossary of Cannabinoid Terms

This brochure (developed by Jazz Pharmaceuticals, CEWG, and a patient advocate) offers a quick overview of many of the cannabinoid terms in use today and non–FDA approved medications.

A large image of a pen signing an important document and warning letters issued by the FDA regarding cannabinoid products

Warning Letters Issued by the FDA Regarding Cannabinoid Products

As part of the FDA’s efforts to protect consumers from health fraud, warning letters have been issued to dispensing companies for illegally selling products online that claim to prevent, diagnose,...

The Basis of Cannabinoid Therapeutics: What You Need to Know article image

The Basis of Cannabinoid Therapeutics: What You Need to Know

The goal of this activity is to provide background on the endocannabinoid system and its potential role in investigational therapies.

Medscape is a free educational website. However, if you are not already a member, you will be prompted to select a free username and password.  

Kandy Kush 50/50 image inside of a jar: Pharmaceutical- vs. dispensary-sourced cannabinoids: what's the difference?

Pharmaceutical- vs Dispensary-Sourced Cannabinoids: What's the Difference?

The goal of this activity is to differentiate pharmaceutical-grade from dispensary-sourced cannabinoids.

This activity has expired, but content is available for viewing.

Medscape is a free educational website. However, if you are not already a member, you will be prompted to select a free username and password.

Cannabis leaf image – Learn about the health effects of cannabis and cannabinoids

Health Effects of Cannabis and Cannabinoids Report

The health effects of cannabis and cannabinoids as studied by the National Academies of Sciences, Engineering, and Medicine’s expert committee.

The Handbook of Cannabis by Roger Pertwee image

Handbook of Cannabis by Roger Pertwee

A 700+ page book by leading researchers from around the world, covering history, pharmacology, potential therapeutic uses, and clinical research of cannabinoids.

JAMA: Labeling Accuracy of Cannabidiol Extracts imagine

JAMA: Labeling Accuracy of Cannabidiol Extracts

The Journal of the American Medical Association (JAMA) published research letters on the labeling accuracy of products sold in dispensaries, online, or in brick-and-mortar shops.

Young Woman Lighting a Joint

Current Cannabis Controversies

A review of issues facing cannabinoid medicine and research by Ethan B. Russo published in Frontiers in Pharmacology.

A close-up picture of a person holding a cannabis bud with visible THC on it

Does the Passage of the 2018 Farm Bill Legalize Non--FDA-Approved Hemp-Derived Cannabinoid Products?

It is not fully clear when hemp-derived cannabinoid products will be federally legal to be sold or how they will be regulated.

Article image: Importance of monitoring drug interactions between medications and cannabinoid products

Importance of Monitoring Drug Interactions Between Medications and Cannabinoid Products

Based on the 4 FDA-approved cannabinoid drugs, these posters provide a quick overview, for the pharmacist and the patient, of possible drug interactions between medications and cannabis products along with possible side effects.

The information is brought to you by Jazz Pharmaceuticals in partnership with the American College of the Apothecaries and Pharmacists Planning Services Inc.

Cannabidiol: A Tale of Two Products. Image of the text cannabinoids on a piece of paper

Cannabidiol: A Tale of Two Products

An educational program that equips pharmacists with current and useful information regarding cannabidiol.

This activity has expired, but content is available for viewing.